Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia. | Blood;98(1): 241-3, 2001 Jul 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia.

Mesters, R M; Padró, T; Bieker, R; Steins, M; Kreuter, M; Göner, M; Kelsey, S; Scigalla, P; Fiedler, W; Büchner, T; Berdel, W E.

Affiliation

Mesters RM; Department of Medicine/Hematology and Oncology, University of Muenster, Germany. mesters@uni-muenster.de

Blood ; 98(1): 241-3, 2001 Jul 01.

Article in En | MEDLINE | ID: mdl-11418488

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Leukemia, Myeloid / Indoles Limits: Female / Humans / Middle aged Language: En Journal: Blood Year: 2001 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Leukemia, Myeloid / Indoles Limits: Female / Humans / Middle aged Language: En Journal: Blood Year: 2001 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos